17 alpha-hydroxyprogesterone caproate has been researched along with Adenocarcinoma in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (58.82) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HENRIKSEN, E; VARGA, A | 1 |
| Botnar', ER; Chernyĭ, AP; Shendereva, TS; Shvedova, LA; Volostnykh, LV | 1 |
| Bassalyk, LS; Ermilova, VD; Kuz'mina, ZV; Murav'eva, NI; Peskova, VI | 1 |
| Bokhman, JV; Chepick, OF; Vishnevsky, AS; Volkova, AT | 2 |
| Bokhman, IaV; Chepik, OF; Vishnevskiĭ, AS; Volkova, AT | 2 |
| Shenderëva, TS; Shvedova, LA | 1 |
| Bochmann, JW | 1 |
| Dyba, T; Karolewski, K; Klimek, M; Kojs, Z; Urbański, K | 1 |
| Chepick, OF | 1 |
| Charkviani, TL | 1 |
| Cao, B; Zhang, X | 1 |
| Adamian, RT | 1 |
| Titova, VA; Voznyĭ, EK | 1 |
| Abeler, V; Kjørstad, K; Kolstad, P; Vergote, I | 1 |
| Bokhman, IaV; Gastev, AIu; Stoliarova, IV | 1 |
6 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Adenocarcinoma
| Article | Year |
|---|---|
Adjuvant progestagen therapy improves survival in patients with endometrial cancer after hysterectomy. Results of one-institutional prospective clinical trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Actuarial Analysis; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Hysterectomy; Middle Aged; Neoplasm Invasiveness; Prognosis; Proportional Hazards Models; Prospective Studies; Radioisotope Teletherapy; Survival Rate; Treatment Outcome | 1993 |
Morphological aspects of the hormone-induced pathomorphosis of endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Antineoplastic Agents; Cell Division; Chemotherapy, Adjuvant; Clomiphene; Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Enzymes; Estradiol; Female; Glycogen; Humans; Hydroxyprogesterones; Microscopy, Electron; Neoplasm Staging; Neoplasms, Hormone-Dependent; Remission Induction | 1993 |
Exploration for drug therapy in endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Squamous Cell; Double-Blind Method; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Middle Aged; Tamoxifen | 1996 |
[Therapy of atypical hyperplasia and adenocarcinoma of the endometrium with the combination of progestins and anticoagulants].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Anticoagulants; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Endometrial Neoplasms; Endometrium; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Hyperplasia; Medroxyprogesterone Acetate; Neoplasm Staging; Progesterone Congeners; Treatment Outcome | 2001 |
A randomized trial of adjuvant progestagen in early endometrial cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Clinical Trials as Topic; Combined Modality Therapy; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Neoplasm Recurrence, Local; Progesterone Congeners; Prognosis; Random Allocation; Risk Factors; Uterine Neoplasms | 1989 |
[Effect of adjuvant hormonotherapy on the results of the radiation treatment of patients with cancer of the corpus uteri].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Random Allocation; Uterine Neoplasms | 1987 |
11 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Adenocarcinoma
| Article | Year |
|---|---|
Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Adenocarcinoma; Adenocarcinoma, Papillary; Caproates; Female; Humans; Hydroxyprogesterones; Progesterone; Uterine Neoplasms | 1961 |
[Combined morphologic evaluation of the efficacy of progestin therapy of primary endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Neoplasm Recurrence, Local; Time Factors; Uterine Neoplasms | 1984 |
[Cytoplasmic steroid hormone receptors in the tumors of endometrial cancer patients].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Combined Modality Therapy; Cytoplasm; Female; Humans; Hydroxyprogesterones; Menopause; Middle Aged; Preoperative Care; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1984 |
Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Female; Humans; Hydroxyprogesterones; Hysterectomy; Postoperative Care; Preoperative Care; Progesterone Congeners; Radiotherapy, High-Energy; Uterine Neoplasms | 1981 |
[Is a cure possible for primary state-I endometrial cancer using drug therapy?].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Antineoplastic Agents; Carcinoma; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydroxyprogesterones; Neoplasm Staging; Preoperative Care; Uterine Neoplasms | 1982 |
[Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Biopsy; Cell Transformation, Neoplastic; Drug Evaluation; Female; Humans; Hydroxyprogesterones; Middle Aged; Progesterone Congeners; Uterine Neoplasms | 1981 |
[Adjuvant gestagen therapy of endometrial carcinoma (author's transl)].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Female; Humans; Hydroxyprogesterones; Hysterectomy; Middle Aged; Neoplasm Staging; Progesterone Congeners; Prognosis; Uterine Neoplasms | 1981 |
Optimal variants of treatment of stage I endometrial carcinoma and its choice.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Retrospective Studies; Survival Rate; Treatment Outcome | 1993 |
[Progestins in combined treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progestins; Uterine Neoplasms | 1990 |
[Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Delayed-Action Preparations; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone Congeners; Tamoxifen; Uterine Neoplasms | 1990 |
Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Hydroxyprogesterones; Methotrexate; Progesterone Congeners; Uterine Neoplasms; Vincristine | 1985 |